Connect treatment evidence with daily function
HEART RESERVE | Fictional case

Elena's A one C is at goal. She also has type two diabetes and a previous heart attack. Those facts raise a separate treatment question: which options have demonstrated cardiovascular benefit for someone like her?

Start with the disease and the outcome, then read the trial population, comparator, benefit, and harms. Greater weight loss does not, by itself, prove greater protection from cardiovascular events. A study that establishes noninferiority has not necessarily shown superiority.

At follow-up, Elena is losing weight, but she has nausea, small meals, and less energy. She can drink and has no severe pain or persistent vomiting. Before the next dose increase, the prescriber and registered dietitian should review symptoms, food and fluids, recent dose changes, and daily function.

Nutrition and suitable resistance activity need to fit her health, abilities, and resources. Persistent vomiting, inability to maintain fluids, or severe persistent abdominal pain needs prompt clinical assessment.

At the next visit, review the intended treatment benefit and what Elena can actually do. Agree who will follow up, when, and what happens if that visit is missed.